Skip to main content

Table 1 Baseline characteristics of individuals: optimal and Sub-optimal weight monitoring adherence from self-reported and diary-recorded measures

From: Self-reported recall and daily diary-recorded measures of weight monitoring adherence: associations with heart failure-related hospitalization

Characteristics

Overall sample

(N = 216)

Self-reported weighing daily or more (N = 184)

Self-reported weighing less than daily (N = 32)

P value

Diary-recorded ≥80% weighing adherence (N = 107)

Diary-recorded <80% weighing adherence (N = 109)

P value

Age (mean, SD)

62.2 (13.9)

62.4 (13.9)

61.1 (13.5)

0.638

64.3 (12.6)

60.1 (14.8)

0.024

Men (N, %)

103 (48)

83 (45)

20 (63)

0.069

45 (42)

58 (53)

0.101

Race/Ethnicity

       

  White, Non-Hispanic

80 (37)

71 (39)

9 (28)

0.024

47 (44)

33 (30)

0.071

  Hispanic

35 (16)

24 (13)

11 (34)

 

12 (11)

23 (21)

 

  African American

87 (40)

76 (41)

11 (34)

 

43 (40)

44 (40)

 

  Other

14 (6)

13 (7)

1 (3)

 

5 (5)

9 (8)

 

NYHA Class (N, %)

       

  I

45 (21)

39 (21)

6 (19)

0.536

23 (21)

22 (20)

0.168

  II

111 (51)

96 (52)

15 (47)

 

61 (57)

50 (46)

 

  III

35 (16)

27 (15)

8 (25)

 

15 (14)

20 (18)

 

  IV

25 (12)

22 (12)

3 (9)

 

8 (7)

17 (16)

 

Study site (N, %)

       

  UNC

87 (40)

80 (43)

7 (22)

<0.001a

56 (52)

31 (28)

<0.001

  Northwestern University

66 (31)

62 (34)

4 (13)

 

33 (31)

33 (30)

 

  UCSF

39 (18)

22 (12)

17 (53)

 

6 (6)

33 (30)

 

  Olive view, UCLA

24 (11)

20 (11)

4 (13)

 

12 (11)

12 (11)

 

Socioeconomic status, median (IQR)

4 (3, 6)

5 (3,7)

4 (1, 5)

0.026b

4 (2, 6)

4 (3, 6)

0.455b

Inadequate literacy (N, %)

74 (34)

59 (32)

15 (47)

0.103

30 (28)

44 (40)

0.06

Heart failure related QOL: Heart failure symptom scale, median (IQR)

61 (43, 79)

61(46, 79)

59 (43, 75)

0.272b

64 (46, 82)

57 (43, 71)

0.014b

Income level

       

  <$15,000

101 (47)

79 (43)

22 (69)

0.052

43 (40)

58 (53)

0.098

  $15,000-$24,999

40 (19)

34 (18)

6 (19)

 

20 (19)

20 (18)

 

  >$25,000

71 (33)

67 (36)

4 (12)

 

41 (38)

30 (28)

 

Previous MI/Angina (N, %)

83 (38)

76 (41)

7 (22)

0.037

49 (46)

34 (31)

0.027

Systolic dysfunction (N, %)

123 (57)

112 (61)

11 (34)

0.005

65 (61)

58 (53)

0.263

ACE-Inhibitor or ARB (N, %)

178 (82)

154 (84)

24 (75)

0.233

86 (80)

92 (84)

0.437

Beta-Blocker (N, %)

176 (81)

153 (83)

23 (72)

0.130

90 (84)

86 (79)

0.324

Thiazide

22 (10)

18 (10)

4 (13)

0.750

10 (9)

12 (11)

0.823

Spironolactone

50 (23)

46 (25)

4 (13)

0.172

22 (21)

28 (25)

0.425

Telephone calls with educator, median (IQR)

16 (14, 18)

16 (15, 18)

15 (13, 16)

<0.001b

17 (16, 18)

15 (13, 17)

<0.001b

Self-reported weighing daily or more at baseline, (N, %)

61 (28)

58 (32)

3 (9)

0.005a

35 (33)

26 (24)

0.148

Taught weight-based diuretic self-adjustment

178 (82)

152 (83)

26 (81)

0.852

87 (81)

91 (83)

0.674

  1. aGroups compared using Fisher’s exact test.
  2. bGroups compared using both t-test and Wilcoxon-Mann–Whitney test.
  3. NYHA: New York Heart Association; MI: Myocardial Infarction; ACE: Angiotensin-Converting Enzyme; ARB: Angiotensin Receptor Blocker; IQR: Interquartile Range; QOL: Quality of Life.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us